Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Novavax’s president and CEO reviewed the company’s successes in 2025 and shared its growth strategy for 2026 and beyond at a ...

Novavax (NASDAQ:NVAX) got a lift early Tuesday after the vaccine maker landed a licensing deal with Pfizer that puts its Matrix-M adjuvant to work in Pfizer's pipeline. Shares of Novavax were up about ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

ETHealthworld.com brings latest takeda pharmaceutical news, views and updates from all top sources for the Indian Health industry.

GSK is set to buy Rapt Therapeutics in a $2.2 billion deal. AstraZeneca agreed to a $630 million pact to secure remaining rights to armored CAR-T from AbelZeta. Bristol Myers Squibb signed a deal with ...

At the JPMorgan Healthcare Conference, Genmab emphasized a long-term growth strategy centered on disciplined R&D investment ...

Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

Texas Biomedical Research Institute, one of the world's leading independent biomedical research institutions dedicated to eradicating infection and advancing health, is celebrating 85 years of bold ...

NEW YORK, NY / ACCESS Newswire / January 20, 2026 / At first glance, the announcement that SMX has opened a corporate account ...

Integrity Urgent Care, a Texas-based family of urgent care clinics dedicated to enhancing communities through convenient, lower-cost and high-quality care, opened its newest clinic in Gatesville, ...

--- ...